Literature DB >> 209883

The effect of estradiol-17-phenylpropionate and estradiol benzoate on N-nitrosomorpholine-induced liver carcinogenesis in ovariectomized female rats.

H S Taper.   

Abstract

The influence of synthetic estrogens on the N-nitrosomorpholine (NNM)-induced liver carcinogenesis in ovariectomized young adult female rats was investigated and compared to rats which received only the carcinogen or estrogens. Estrogens when chronically administered after the cessation of carcinogen treatment increased the carcinogenic effect of NNM. In such conditioned animals the number of nodules per number of rats was 23/31, that of hepato-cellular carcinomas 9/31, whereas in animals which received only the hepato-carcinogen the incidence of nodules and carcinomas in liver was respectively 11/31 and 3/31. Higher incidence of benign and malignant tumors in other organs was also observed in these animals. Rats which received a single dose of estrogens simultaneously with NNM developed slightly fewer tumors in liver and in other organs. Since under my experimental conditions the long-term treatment with synthetic estrogens alone did not induce any focus, nodule or hepatocellular carcinoma in the liver. I suggest that the estrogens were acting rather as tumor promotors than true initiators of liver carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 209883     DOI: 10.1002/1097-0142(197808)42:2<462::aid-cncr2820420213>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

Review 1.  Tumor promotion in the liver.

Authors:  R Schulte-Hermann
Journal:  Arch Toxicol       Date:  1985-08       Impact factor: 5.153

2.  Age-dependent sensitivity of Big Blue transgenic mice to the mutagenicity of N-ethyl-N-nitrosourea (ENU) in liver.

Authors:  Nan Mei; Robert H Heflich; Martha M Moore; Tao Chen
Journal:  Mutat Res       Date:  2005-05-02       Impact factor: 2.433

3.  Abnormal sex-steroid milieu in young adults with hepatocellular carcinoma.

Authors:  R A Malt; J J Galdabini; B W Jeppsson
Journal:  World J Surg       Date:  1983-03       Impact factor: 3.352

4.  Oral contraceptives and benign tumors of the liver.

Authors:  J G Fitz
Journal:  West J Med       Date:  1984-02

5.  Hepatocellular alterations after intraportal transplantation of ovarian tissue in ovariectomized rats.

Authors:  L Klotz; H J Hacker; D Klingmüller; P Bannasch; U Pfeifer; F Dombrowski
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

6.  Estrogen receptors in hepatocellular carcinoma: is endocrine therapy for hepatocellular carcinoma likely to be effective?

Authors:  K Kohigashi; Y Fukuda; H Imura
Journal:  Gastroenterol Jpn       Date:  1987-06

Review 7.  Tamoxifen and secondary tumours. An update.

Authors:  N Wilking; E Isaksson; E von Schoultz
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

8.  Clinicopathologic comparisons between estrogen receptor-positive and -negative hepatocellular carcinomas.

Authors:  N Nagasue; H Kohno; Y C Chang; A Yamanoi; T Nakamura; H Yukaya; T Hayashi
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

9.  Induction of monooxygenases and growth in rat liver by progesterone.

Authors:  H Ochs; B Düsterberg; R Schulte-Hermann
Journal:  Arch Toxicol       Date:  1986-10       Impact factor: 5.153

10.  Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats.

Authors:  Y P Dragan; S Fahey; K Street; J Vaughan; V C Jordan; H C Pitot
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.